Thomson, David J., et al. “Dose Intensified Hypofractionated Intensity-Modulated Radiotherapy With Synchronous Cetuximab for Intermediate Stage Head and Neck Squamous Cell Carcinoma”. Acta Oncologica, vol. 54, no. 1, Jan. 2015, pp. 88-98, doi:10.3109/0284186X.2014.958528.